Joan Antoni Gómez-Hospital

Watch time: 3h 22m 24s (23 videos)


Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Visit our Heart Failure Management Hub to discover a range of educational content to facilitate the use of SGLT-2 inhibitors and other guideline directed medical therapies as foundational treatment for HF.


Annual Update: The State of the Field in Cardiac Unloading


28 June 2022


Interventional Cardiology Review 2022;17(Suppl 1):5.

A Review of the Impella Devices


08 April 2022


Interventional Cardiology 2022;17:e05.

Futility in TAVI


18 January 2022


Interventional Cardiology 2022;17:e01.

Haemodynamic Assessment Before and After LVAD Implant


24 December 2021


Interventional Cardiology 2021;16:e34.